This provides the body with large amounts of antioxidants
Januvia (sitagliptin) is a DPP-4 inhibitor taken as a once-daily oral tablet
Managing expectations about adjustment periods helps patients distinguish between temporary adaptation and true intolerance
3 Synthetic GLP-1 agonists are resistant to degradation by DPP-4, increasing the half-life of their actions by several fold
While enteral administration offers several advantages over other routes of drug delivery in terms of convenience, promoting medication compliance, it faces several obstacles, of which the most widely recognized are inefficient absorption owing to physical barriers and an acidic microenvironment, along with degradation by proteases and the first-pass metabolism in the liver
Obese individuals from lower socioeconomic backgrounds face additional healthcare costs, spending, on average, over $1,800 more annually than those without obesity